antisense oligonucleotides (Oncbiomune)

N/A

Report date: 2025/03/14 16:32:21
NME

Base Information

Drug Nameantisense oligonucleotides (Oncbiomune)
Drug Alias Nameantisense therapy (Oncbiomune)
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Oligonucleotide antisense
Mechanisms of ActionAntisense oligonucleotide inhibitors
TargetsUpdating
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesTheralink Technologies
China Registration ClassN/A

Develop Information

Active CompaniesTheralink Technologies
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A